Treatment for non-alcoholic fatty liver diseases
AssigneeDsm IP Assets B.V.
InventorsSzabolcs PETER, Joseph SCHWAGER
Life of this patent
Estimating the term…
Abstract
Mixtures of vitamin E and polyunsaturated fatty acids (PUFAs) are provided as agents for the prevention, control and/or treatment of conditions associated with excessive fat accumulation in the liver which is not caused by alcohol abuse, including control and/or treatment of non-alcoholic steatosis in the liver—known as non-alcoholic fatty liver disease (NAFLD)—and/or non-alcoholic steatohepatitis (NASH) in a subject in need thereof.
Claims10
A method of treating a patient having non-alcoholic steatohepatitis and/or non-alcoholic fatty liver disease which comprises administering to a patent in need of treatment for non-alcoholic steatohepatitis and/or non-alcoholic fatty liver disease a treatment effective amount of a composition comprising vitamin E and polyunsaturated fatty acid (PUFA) in a weight ratio of the vitamin E to the PUFA of about 1:1 to about 5:1.
Dependencies are inferred from the claim text.